BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 17411511)

  • 1. The debate on breast cancer screening with mammography is important.
    Gøtzsche PC
    J Am Coll Radiol; 2004 Jan; 1(1):8-14. PubMed ID: 17411511
    [No Abstract]   [Full Text] [Related]  

  • 2. Delayed benefit of mammography screening in premenopausal women.
    Jatoi I; Soballe PW; Anderson WF
    J Clin Oncol; 2004 Dec; 22(23):4860; author reply 4860-2. PubMed ID: 15570095
    [No Abstract]   [Full Text] [Related]  

  • 3. Screening for breast cancer.
    Duffy SW; Smith RA; Gabe R; Tabár L; Yen AM; Chen TH
    Surg Oncol Clin N Am; 2005 Oct; 14(4):671-97. PubMed ID: 16226686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Does organized mammographic screening reduce breast cancer mortality? The Cancer Registry's view on the current debate].
    Wang H; Hofvind S; Tretli S; Thoresen S; Langmark F
    Tidsskr Nor Laegeforen; 2002 Jan; 122(2):211-3. PubMed ID: 11873583
    [No Abstract]   [Full Text] [Related]  

  • 5. Screening mammography may not be effective at any age.
    Wilkerson BF; Schooff M
    J Fam Pract; 2000 Apr; 49(4):302, 371. PubMed ID: 10778833
    [No Abstract]   [Full Text] [Related]  

  • 6. [Survey of a Cochrane review concerning sequencing of adjuvant chemotherapy and postoperative radiotherapy in breast cancer].
    Nielsen HM; Overgaard M
    Ugeskr Laeger; 2007 Sep; 169(37):3101-4. PubMed ID: 17877959
    [No Abstract]   [Full Text] [Related]  

  • 7. [Reduced mortality with mammographic screening. The natural course, too rough methods resulted in miscalculation on breast cancer].
    Rutqvist LE
    Lakartidningen; 1999 Mar; 96(10):1210-1. PubMed ID: 10193130
    [No Abstract]   [Full Text] [Related]  

  • 8. Screening mammography in women 40 to 49 years of age: yes.
    Kopans DB
    Important Adv Oncol; 1995; ():231-41. PubMed ID: 7672809
    [No Abstract]   [Full Text] [Related]  

  • 9. A stochastic simulation model of U.S. breast cancer mortality trends from 1975 to 2000.
    Plevritis SK; Sigal BM; Salzman P; Rosenberg J; Glynn P
    J Natl Cancer Inst Monogr; 2006; (36):86-95. PubMed ID: 17032898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Mass screening of cancer of the breast: politico-economic objectives and their underestimated risks].
    Dilhuydy MH
    Contracept Fertil Sex; 1998 Jun; 26(6):420-4. PubMed ID: 9691519
    [No Abstract]   [Full Text] [Related]  

  • 11. Mammography surveillance and mortality in older breast cancer survivors.
    Lash TL; Fox MP; Buist DS; Wei F; Field TS; Frost FJ; Geiger AM; Quinn VP; Yood MU; Silliman RA
    J Clin Oncol; 2007 Jul; 25(21):3001-6. PubMed ID: 17548838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MRI and mammography surveillance of women at increased risk for breast cancer: recommendations using an evidence-based approach.
    Granader EJ; Dwamena B; Carlos RC
    Acad Radiol; 2008 Dec; 15(12):1590-5. PubMed ID: 19000876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of magnetic resonance imaging in screening women at high risk of breast cancer.
    Warner E
    Top Magn Reson Imaging; 2008 Jun; 19(3):163-9. PubMed ID: 18941396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening mammography in women 40 to 49 years of age: no.
    Baines CJ
    Important Adv Oncol; 1995; ():243-51. PubMed ID: 7672810
    [No Abstract]   [Full Text] [Related]  

  • 15. The effect of service screening on breast cancer mortality rates.
    Cox B
    Eur J Cancer Prev; 2008 Aug; 17(4):306-11. PubMed ID: 18562953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cancer screening: medico-legal aspects].
    Buzzi F
    Ann Ig; 2003; 15(1):3-10. PubMed ID: 12666320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The European experience.
    Höffken K
    J Clin Oncol; 2001 Sep; 19(18 Suppl):112S-117S. PubMed ID: 11560985
    [No Abstract]   [Full Text] [Related]  

  • 18. The mammography screening controversy.
    Kopans DB
    Cancer J Sci Am; 1998; 4(1):22-4. PubMed ID: 9467041
    [No Abstract]   [Full Text] [Related]  

  • 19. The MISCAN-Fadia continuous tumor growth model for breast cancer.
    Tan SY; van Oortmarssen GJ; de Koning HJ; Boer R; Habbema JD
    J Natl Cancer Inst Monogr; 2006; (36):56-65. PubMed ID: 17032895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening mammography in women 40 to 49 years of age.
    Lisby MD
    Am Fam Physician; 2004 Nov; 70(9):1750-2. PubMed ID: 15554494
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 20.